Since visceral fat (fat around the abdomen) is closely linked to metabolic health issues, reducing it can significantly improve conditions like insulin resistance, high cholesterol, and cardiovascular risk
Looking ahead, the next phase of obesity medicine will likely see GLP-1 medications used in combination with other weight loss agents, as well as expanded research into their effects on conditions like high blood pressure, heart attack risk, and liver disease
Key facts for patients: Approved December 22, 2025
Aslight overfill of 1 Unit (0.01 mL) is includedintentionally
Managing and Preventing Leg Cramps on Wegovy If you experience leg cramps whilst taking Wegovy, several practical strategies may help manage and prevent them